24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Ronen Nir
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:00
Batsheva Moshe appointed GM Israel market & EMEA tech at Kaltura
16:00
AstraZeneca expands AI partnership with Immunai in deal worth up to $37.5 million
15:20
The strong shekel is becoming Israel’s next economic crisis
14:52
Airport congestion pushes Israel to relocate American aircraft
More stories
Buzz
Most popular
Daily
Weekly
1
From defense giants to startups: Israel reconsiders how it buys weapons
2
Five bidders advance in Nice’s $2.5 billion Actimize sale process
3
Kela raising $200 million at $1 billion valuation with backing from Bill Ackman and Eric Schmidt
4
Cisco acquires AI security startup Astrix for $400 million
5
The 50 most promising Israeli startups - 2026
More news
Ronen Nir
4 stories about Ronen Nir
“If I could, I’d recruit everyone abroad”: Israeli tech feels currency squeeze
07.05.26
|
Sophie Shulman
Startup founders say strong shekel is undermining competitiveness.
Ronen Nir to no longer be involved in new Viola investments
11.05.21
|
Meir Orbach
Nir, a managing partner at the venture capital firm, will remain active with past investments
Ronen Nir sets sights on becoming the next CEO of the Israel Innovation Authority
10.11.20
|
Meir Orbach
Since the outbreak of the Covid-19 pandemic, Nir of Viola Ventures has been a vocal voice on social media regarding the effects of the crisis on the local tech industry and entrepreneurs
Adapting to a New Normal Is the Key to Economic Recovery
07.04.20
|
Allon Sinai
Ronen Nir, general partner at investment group Viola Ventures, talked to CTech about the lessons learned from the coronavirus pandemic and what to expect next